Vitamin D and PCOS/PMOS

If you have PCOS, your doctor has probably told you to "take some vitamin D." Maybe they checked a level, maybe they didn't. Either way, you walked out with a recommendation that came without much context. Then you stood in front of the supplement shelf, looking at 400 IU softgels next to 1,000 IU capsules next to 5,000 IU drops, and the simple instruction suddenly had three orders of magnitude in it and no clear answer for which one is actually meant for you.

The reason vitamin D keeps coming up in PCOS conversations is not that it is a treatment for the condition. It is not. What vitamin D does is sit underneath several of the metabolic loops driving the symptoms you are actually experiencing — and women with PCOS run deficient in it for specific, biological reasons that have nothing to do with how much sun you get or how clean your diet is.

Polycystic ovary syndrome (PCOS) — also called polyendocrine metabolic ovarian syndrome (PMOS) in recent medical literature following the 2026 Lancet consensus rename (Teede et al. 2026) — is a multisystem endocrine-metabolic condition, not a localized ovarian one. That framing matters here because the part of PCOS that interacts with vitamin D is exactly the metabolic side: the insulin resistance, the inflammatory tone, the way your body stores fat. This guide walks through why deficiency is so common in PMOS/PCOS, what correcting it does and does not do, and how vitamin D fits alongside the more directly load-bearing interventions for the condition.

Why is vitamin D deficiency so common in PCOS?

Vitamin D deficiency in PCOS is not primarily a sunlight problem or a dietary problem. It is a fat-storage problem.

Vitamin D is technically a fat-soluble secosteroid — chemically, it behaves more like a hormone than a vitamin. Because it is fat-soluble, vitamin D is actively sequestered by adipose tissue (your fat tissue). The more body fat you carry, and especially the more visceral belly fat, the more vitamin D gets trapped in storage rather than circulating in your bloodstream where it can do its work.

For roughly 70 percent of women with PCOS, the central driver of the condition is insulin resistance. Your muscle and fat cells stop responding to insulin the way they should, so your pancreas compensates by pumping out more of it to keep your blood sugar normal. That steadily rising insulin acts directly on the cells in your ovaries, hyper-stimulating them to overproduce testosterone, and it simultaneously tells your liver to stop producing sex hormone-binding globulin — a protein that normally binds up loose testosterone in your blood (Diamanti-Kandarakis & Dunaif 2012). When SHBG drops, more testosterone is left free and active to drive acne, hair changes, and the rest of the visible symptom picture (Goodarzi et al. 2011).

The same insulin-driven loop also expands visceral fat — the deeper fat layer that wraps your abdominal organs — and that expanded fat tissue then acts as a vitamin D sink. It absorbs the vitamin D your skin makes from sunlight and the vitamin D you get from food or supplements, pulling it out of circulation and locking it into storage. The clinical consequence is that you can be taking a standard over-the-counter multivitamin, getting reasonable sun exposure, and still show a clinically low circulating vitamin D level on a blood test. Women with PCOS frequently need more vitamin D than the population average just to reach the same circulating level — the fat tissue has to be saturated first, and only the spillover stays in your blood where it can bind to receptors and signal.

How does vitamin D actually affect PCOS symptoms?

Once vitamin D reaches your bloodstream, your liver converts it into its main circulating form, 25-hydroxyvitamin D (also called calcifediol). This is the form your doctor measures on a blood test. Your kidneys then convert that into the active form, calcitriol, which acts on a receptor present in nearly every tissue in your body — including ovary, muscle, fat, immune cells, and the cells lining your gut.

That receptor — the vitamin D receptor (VDR) — regulates the expression of thousands of genes, including ones involved in how your cells respond to insulin. When you are deficient, that signaling pathway is impaired. Your peripheral tissues respond less well to insulin than they otherwise would, which adds to the baseline insulin resistance PCOS is already driving. Correcting the deficiency removes one of the compounding variables sitting on top of the metabolic loop.

This is where the clearest evidence for vitamin D in PCOS lives. A 2018 systematic review and meta-analysis pooled 11 randomized controlled trials covering 601 women with PCOS and found that vitamin D supplementation significantly reduced fasting glucose and improved Homeostatic Model Assessment for Insulin Resistance (HOMA-IR) scores compared to placebo. The strongest insulin-sensitivity effect appeared at supplementation doses below 4,000 IU per day (Łagowska et al. 2018).

What that meta-analysis does not show is vitamin D causing weight loss or restoring ovulation on its own. The improvements are in the markers of insulin resistance — fasting glucose and HOMA-IR — not in body weight, hirsutism scores, or pregnancy rates. Vitamin D removes a barrier that makes your insulin resistance worse than it has to be; it does not directly reverse the underlying PCOS loop.

Does vitamin D help with inflammation in PCOS?

The other place vitamin D acts is on your immune system. The active form of vitamin D modulates the inflammatory signaling molecules called cytokines, and acts as a mild brake on the inflammatory cascade. This matters in PMOS/PCOS because the condition is increasingly understood as a chronic, low-grade inflammatory state.

Visceral belly fat releases inflammatory chemicals — including tumor necrosis factor-alpha (TNF-alpha) and interleukin-6 (IL-6) — that travel through your bloodstream and directly interfere with insulin signaling in your peripheral tissues (Randeva et al. 2012). The same inflammation amplifies the prostaglandin response that drives period pain, primes the inflammatory side of hormonal acne, and contributes to the systemic background mood and energy run against. This is one of the central reasons the rename to PMOS was proposed — to recognize that the inflammatory and metabolic side of the syndrome reaches well beyond the ovaries.

Keeping vitamin D replete provides your immune system with one of the signaling tools it uses to keep this inflammatory tone in check. The dedicated trial evidence for "vitamin D reduces inflammation in PCOS" specifically is less developed than the insulin-sensitivity evidence — most PCOS trials measure glucose and HOMA-IR rather than inflammatory markers — but the mechanistic case is solid and consistent with the metabolic improvement the meta-analysis documented.

Among Functional Medicine and integrative-nutrition practitioners, the four-type framework is commonly used to categorize how PCOS presents: insulin-resistant, post-pill, inflammatory, and adrenal. For women whose presentation leans heavily inflammatory — chronic fatigue, joint pain, skin reactivity, bloating, autoimmune overlap — keeping vitamin D replete is one of the foundational levers, less because vitamin D is a powerful anti-inflammatory on its own and more because being deficient amplifies every other inflammatory input. The same applies to the broader mood picture: women with PCOS face roughly a four-fold increased risk of moderate-to-severe depressive and anxiety symptoms compared to women without it (Cooney et al. 2017), and vitamin D deficiency is one of the more reliably documented contributors to low mood and fatigue across the general population.

Can vitamin D lower your risk of gestational diabetes?

If you are planning a pregnancy, your vitamin D status moves from a metabolic background variable to an immediate clinical priority.

PCOS is an independent risk factor for gestational diabetes. The baseline risk women with PCOS carry for impaired glucose tolerance and type 2 diabetes is more than four times higher than women without the condition (Moran et al. 2010). That risk does not pause when you conceive; it gets amplified. During pregnancy, your placenta releases hormones — primarily human placental lactogen, progesterone, and others — that intentionally make your tissues resist insulin so more glucose stays available for the growing baby. If you walk into pregnancy with preexisting insulin resistance from PMOS/PCOS, your pancreas is already working harder than baseline; the additional placental demand on top can overwhelm it, and blood glucose stays elevated.

Low circulating vitamin D during pregnancy is associated with higher rates of gestational diabetes, pre-eclampsia, and small-for-gestational-age infants. Because the expanded adipose tissue in many women with PCOS sequesters vitamin D and lowers circulating levels, women with the condition walk into pregnancy with a compounded risk for deficiency layered on top of an already elevated metabolic risk. Correcting vitamin D status before conception removes one compounding variable from a risk profile that is already running higher than average.

For a fuller walk-through of how prenatal supplementation fits the PCOS picture — what a standard prenatal does and does not cover, which targeted supplements belong alongside it — our guide on prenatal vitamins for PCOS covers the preconception window in detail.

How do you know if you are vitamin D deficient?

You do not guess this. You measure it.

The blood test you ask your doctor for is a 25-hydroxyvitamin D test, sometimes labeled 25(OH)D or calcifediol. This is the main circulating form of vitamin D and the standard biomarker for status. The result comes back as either nanograms per milliliter (ng/mL) or nanomoles per liter (nmol/L) depending on your lab (1 ng/mL = 2.5 nmol/L).

There is no single universally agreed-upon threshold, but the broad clinical conventions used in the supplementation literature run something like this. Levels below 20 ng/mL (50 nmol/L) are generally classified as deficient. Levels between 20 and 30 ng/mL (50–75 nmol/L) are typically described as insufficient. Most integrative-medicine practitioners working with PCOS target a circulating level somewhere in the 30 to 50 ng/mL (75–125 nmol/L) range. These thresholds are clinical conventions rather than RCT-derived optimal numbers for PMOS/PCOS specifically — no large randomized trial has established the precise circulating level that maximizes metabolic outcomes in women with the condition.

The reason testing matters more for women with PCOS than for the general population is the adipose-sequestration effect. Two women taking the same daily dose can end up with very different circulating levels depending on how much fat tissue is holding the supplement in storage. Without a blood test, you are guessing at both your starting point and whether your dose is reaching your bloodstream.

Retest at three months after starting supplementation. That is roughly the time it takes circulating 25(OH)D to reach a new steady state at a given daily intake, and it gives you actual data instead of supplement-shelf guesswork for the next dose adjustment.

What form of vitamin D should you take?

Two forms appear on supplement labels: vitamin D2 (ergocalciferol) and vitamin D3 (cholecalciferol). They are not interchangeable.

Vitamin D3 is the form your skin makes from sunlight, and the form found in animal-source foods like fatty fish and egg yolks. Vitamin D2 is plant-derived and is the form most commonly used in older fortified foods and some prescription products. Across head-to-head comparisons, vitamin D3 raises circulating 25-hydroxyvitamin D levels more efficiently than D2 at the same dose, and maintains higher levels for longer between doses. For a deficiency you are actively trying to correct, D3 is the form to take.

The carrier matters too. Because vitamin D is fat-soluble, it absorbs much better when taken with a meal containing some dietary fat than on an empty stomach. A vitamin D supplement taken with a fat-free breakfast is partially wasted. Taking it with eggs, avocado, olive oil, fish, full-fat yogurt, or any meal with meaningful fat content roughly doubles the absorption efficiency.

Many vitamin D supplements are co-formulated with vitamin K2 (menaquinone). The integrative-nutrition rationale for the pairing is that K2 directs calcium toward bones and teeth and away from soft tissue like arteries — relevant when you are increasing vitamin D's role in calcium handling. The dedicated trial evidence for D3 + K2 combinations specifically in PCOS is limited, and most of the supplementation RCTs in the Łagowska meta-analysis used D3 alone or D3 with calcium. The pairing is reasonable; it is not the load-bearing decision.

How much vitamin D should you take for PCOS?

The honest framing first: a precise daily international-unit count for PCOS specifically has not been established by a large randomized trial. The dosing patterns below come from the supplementation studies in the Łagowska meta-analysis, broader vitamin D clinical practice, and clinical-nutrition practitioner convention. They are not RCT-derived PMOS-specific therapeutic doses. Your specific dose should be calibrated to your bloodwork in conversation with your healthcare provider.

The general daily intake reference for adult women is 600 to 800 IU per day, set primarily to maintain skeletal health in the general population. That reference assumes a person with adequate sun exposure, no significant adipose sequestration, and an already-replete baseline. It is not designed for someone with a documented deficiency and PCOS-driven fat-storage that pulls vitamin D out of circulation.

The Łagowska meta-analysis found the strongest improvement in insulin sensitivity and fasting glucose in women with PCOS at supplementation doses below 4,000 IU per day (Łagowska et al. 2018). That range — under 4,000 IU per day — is also the level the broader endocrinology literature generally considers safe for sustained daily use in adults without medical supervision.

For deficiency correction specifically, integrative-medicine practitioners and endocrinologists often use a temporary higher-dose loading phase to bring a clearly low circulating level back into the sufficient range, followed by a long-term maintenance dose that holds it there. The maintenance dose for an adult woman with PCOS frequently sits somewhere between 1,000 and 4,000 IU of vitamin D3 per day, depending on baseline level, body weight, and ongoing sun exposure. Loading doses — sometimes prescribed as a once-weekly higher dose for several weeks — should be set by your provider against your actual lab result, not picked off a supplement shelf.

The tolerable upper intake level set by mainstream endocrinology guidelines is 4,000 IU per day for daily, unmonitored, long-term use. Higher doses are sometimes used clinically under physician supervision when a deficiency is severe, but unmonitored high-dose use carries a real risk of toxicity over months because vitamin D is fat-soluble and accumulates. Symptoms of vitamin D toxicity — nausea, weakness, kidney problems from elevated calcium — show up at sustained intakes well above the upper limit, but the principle holds: this is not a supplement to take massive doses of without testing.

If you do not have access to a recent 25(OH)D blood test, a daily dose of 1,000 to 2,000 IU of vitamin D3 taken with a meal containing fat is a conservative starting point for an adult woman with PCOS, with a test at three months to confirm the dose is reaching its target circulating level.

Why magnesium matters for vitamin D to actually work

Vitamin D does not work alone. The enzymes your liver and kidneys use to convert vitamin D into its active form require magnesium as a cofactor. If you are magnesium-deficient — which most adult women are, partly from soil mineral depletion in food and partly from chronic stress burning through magnesium stores — your body can take the vitamin D and still fail to fully activate it.

This is one of the more under-recognized pieces of the vitamin D conversation. A woman can be supplementing consistently, see her 25(OH)D level rise on a blood test, and still feel limited effect because the downstream activation step is bottlenecked at the magnesium-requiring enzymes. For a fuller walk-through of magnesium forms, dosing, and which form addresses which symptom, our guide on magnesium for PCOS covers the topic directly. The short version for vitamin D supplementation: magnesium glycinate at roughly 200 to 300 mg of elemental magnesium per day, taken with food, alongside your vitamin D, is the most common pairing in integrative-nutrition protocols.

Does vitamin D help with PCOS-related acne?

The relationship between vitamin D and hormonal acne is indirect. Vitamin D does not bind to androgen receptors. It does not block the 5-alpha reductase enzyme that converts testosterone into the stronger form (DHT) at your skin. It does not reduce sebum production at the sebaceous gland directly. The acne mechanism in PCOS runs through insulin, androgens, SHBG, and the inflammatory response at the pore — and vitamin D acts on the upstream insulin signaling and the inflammatory tone, not on the skin.

In practice: vitamin D is not the first-line supplement to reach for if your primary complaint is jawline acne. The supplements with the most direct mechanism for hormonal acne are insulin-sensitizing (inositol), anti-inflammatory at the systemic level (omega-3), and at the skin level (zinc). For the full layered picture, our guide on the top supplements for hormonal acne in PCOS walks through each one.

Where vitamin D matters for the acne picture is as the foundation underneath. If you are deficient, your insulin resistance is worse than it otherwise would be, your inflammatory tone runs higher, and the upstream loop driving androgens to your skin runs hotter. Correcting the deficiency removes a compounding variable without being the direct intervention.

Does vitamin D help with PCOS weight loss?

Only indirectly, and only through the insulin pathway. Vitamin D is not a fat-loss supplement. It does not raise your metabolic rate, suppress your appetite, or directly burn fat. The Łagowska meta-analysis is explicit that vitamin D supplementation in PCOS improves the insulin-resistance markers (fasting glucose, HOMA-IR) but does not produce weight loss on its own.

The reason vitamin D still belongs in the weight conversation is that the visceral-fat pattern most insulin-resistant women experience is fundamentally an insulin problem, not a calorie problem. High circulating insulin acts as a fat-storage hormone and actively blocks the breakdown of stored fat for energy. Until you lower your fasting and post-meal insulin levels, your body remains chemically locked in storage mode. Vitamin D supports the cellular insulin-signaling environment; it does not move weight by itself, but it removes a barrier that makes weight harder to reach.

The interventions that actually move the visceral fat in PCOS are well-evidenced. Foundational lifestyle modification — roughly 150 to 250 minutes of moderate exercise per week and an initial 5 percent weight-loss target — remains first-line management (Teede et al. 2018), and the 2023 international evidence-based guidelines reaffirm that lifestyle and nutritional foundations are the starting point for the condition (Teede et al. 2023). A 16-week trial of a low-glycemic-load pulse-based diet (lentils, beans, chickpeas) produced significantly greater reductions in insulin and improved lipid profiles in PCOS women compared to a standard healthy diet (Kazemi et al. 2018). Vitamin D sits underneath that work. For the broader supplement picture in PMOS/PCOS weight management — how vitamin D fits alongside inositol, magnesium, omega-3, and the others — our guide on PCOS weight loss supplements and vitamins walks through each piece.

What vitamin D cannot do

Vitamin D is not a treatment for PCOS. It does not single-handedly lower your testosterone. It does not restart ovulation. It does not directly clear hormonal acne, shrink visceral belly fat, or regulate your cycle. The clinical-trial signal sits at the level of metabolic markers — insulin sensitivity, fasting glucose — not at the level of reproductive outcomes or symptom reversal.

What vitamin D does is remove one of the foundational deficiencies that quietly amplifies every other PCOS loop. If you are deficient, your cells respond less well to insulin. Your inflammatory tone runs higher. Your mood and energy carry an additional load. Your pregnancy-related metabolic risk is compounded. Each of those is real, even though none of them is the direct cause of your PMOS/PCOS.

The way the evidence base shakes out is this. The interventions with the strongest direct effect on the underlying PCOS loop are dietary glycemic-load reduction, foundational lifestyle modification, inositol at the 40:1 myo to D-chiro ratio for insulin signaling and ovulation, and pharmacological options like metformin or letrozole where clinical indication justifies them. Vitamin D is not on that direct-intervention list. What vitamin D is, used carefully and tested honestly, is one of the more reliable foundational corrections you can make — cheap to test, well-tolerated, with consistent meta-analysis evidence for moving the metabolic markers PMOS itself is built around.

If you are trying to untangle whether your fatigue, your stalled weight, your skin reactivity, or your irregular cycles are driven by insulin resistance, by inflammation, by an adrenal-driven pattern, or by a foundational nutrient gap, the work starts with measurement rather than guessing. Get your 25-hydroxyvitamin D level tested. If it is low, correct it with vitamin D3 taken with a fat-containing meal, paired with magnesium, at a dose calibrated to your bloodwork and rechecked at three months. Then layer the more directly evidence-based interventions on top of that foundation. To understand more about how PCOS reaches well beyond the ovaries and why the condition was renamed to recognize its systemic nature, our guide on what the PMOS name change means for women walks through the broader picture vitamin D sits inside.